Details

---

Manufacturer
Lotus Pharmaceutical Co., Ltd. Nantou Plant(TAIWAN)

Registraction Number
MAL24126026AZ

Content:
Each capsule contains:
-Pomalidomide: 3 mg
Indications:
Multiple Myeloma: Used in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide.
Instructions:
Dosage: The recommended dose is 4 mg orally once daily on Days 1-21 of repeated 28-day cycles until disease progression or unacceptable toxicity.
Administration: Swallow the capsule whole with water. It can be taken with or without food. Follow your doctor's instructions regarding the timing and duration of the medication.